Provision, distribution, and cost of drugs in Canada / Research and Statistics Division, Department of National Health and Welfare. : Z1-1961/3-1-7E-PDF

"During the past four years the entire spectrum of costs, profits and prices of drugs has been intensively discussed by the Canadian public. The first formal investigation of recent importance on this continent was that undertaken in the United States by the Senate Subcommittee on Antitrust and Monopoly (the Kefauver Committee). This committee's inquiry was followed in Canada by the investigation on the manufacture, distribution and sale of drugs undertaken by the Director of Investigation and Research under the Combines Investigation Act. His study was, in turn, followed by hearings initiated by the Federal Restrictive Trade Practices Commission to ascertain whether or not price-fixing of drugs exists at any, or all three, of the manufacturing, distributing and retailing levels. The primary aim has been to include constructive and factual information derived from objective evidence within the Canadian context"--Introduction.

Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.895302&sl=1

• Format MARC XML
• Format MARC HTML

Demander des formats alternatifs